HHHirofumi Hirao

Hirofumi Hirao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hirofumi Hirao has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pancreas–Intestine Composite Transplantation for Simultaneous Loss of Pancreatic and Intestinal Function (With Video)

    by Kei Yamane, Takashi Ito, Takayuki Anazawa, Junji Fujikura, Makoto Okabe, Satoshi Ishida, Koki Kurahashi, Masaaki Hirata, Hiroshi Kawamoto, Hiroto Nishino, et al.

    Pancreas–intestine composite transplantation (PITx) is a therapeutic option for patients with irreversible loss of both pancreatic and intestinal function. We report a case of PITx in a 16‐year‐old male who developed fulminant Type 1 diabetes mellitus complicated by non‐occlusive mesenteric ischemia, resulting in extensive intestinal necrosis. Despite intensive surgical and critical care management, the patient ultimately required total small intestinal resection and total pancreatectomy. After recovery from sepsis and multiorgan dysfunction, the patient's general condition stabilized, and PITx was considered an appropriate therapeutic option. The composite graft consisted of the pancreas, duodenum, small intestine, and right colon. Arterial inflow was reconstructed using a single Carrel patch incorporating the celiac axis and superior mesenteric artery, and venous outflow was established by portal vein anastomosis. Postoperatively, pancreatic endocrine function was restored, allowing stable glycemic control without exogenous insulin, and intestinal graft function enabled the gradual advancement of enteral and oral nutrition. This report highlights the key technical considerations and anatomical principles of PITx and demonstrates that tailored composite graft transplantation can restore both pancreatic and intestinal function while preserving unaffected abdominal organs in highly selected patients with combined pancreatic and intestinal failure.

  • Open Access

    Daikenchuto and Processed Ginger Alleviate Liver Ischemia–Reperfusion Injury by Enhancing Anti‐Inflammatory Effects and HO ‐1 Production

    by Kenichi Saga, Yoichiro Uchida, Hiroshi Kawamoto, Hirofumi Hirao, Yosuke Umino, Masaaki Ito, Yuki Kidoguchi, Junya Kawasoe, Kosuke Tanaka, Kentaro Kadono, et al.

    Background and Aim: Daikenchuto (DKT), a Kampo medicine, is widely used in surgical practice because of its pro‐motility effects on the gastrointestinal tract. Although its anti‐inflammatory effects in the gastrointestinal tract have been well documented, its role in hepatic ischemia–reperfusion injury (IRI) remains unclear. This study investigated the protective effects of DKT and its individual components against hepatic IRI. Methods: Male C57BL/6 mice were fed a diet containing 3.6% DKT or its individual herbal components for 1 week before 60 min of partial hepatic ischemia. Liver injury was evaluated based on serum liver enzyme levels, histology, and TUNEL staining. Portal venous adrenomedullin (ADM) levels and hepatic heme oxygenase‐1 (HO‐1) expression were also assessed. In vitro, peritoneal macrophages were stimulated with High Mobility Group Box 1 (HMGB1) to examine the effects of DKT and 6‐shogaol (6SG). Results: DKT significantly reduced serum alanine aminotransferase levels, necrotic area, and hepatocyte apoptosis compared to the control. Although single‐herb doses equivalent to those in the DKT formula did not confer protection, a threefold dose of processed ginger reproduced the hepatoprotective effects of DKT. DKT did not increase portal ADM levels. In contrast, both DKT and 6SG significantly upregulated HO‐1 expression in vivo and suppressed the production of inflammatory cytokines in HMGB1‐stimulated macrophages in vitro. Conclusion: DKT attenuates liver IRI via HO‐1 induction and suppression of macrophage‐mediated inflammation, rather than via ADM elevation. These protective effects may be mediated, at least in part, by processed ginger.

  • Treatment Interval as a Prognostic Marker in Patients Undergoing Repeated Curative‐Intent Local Treatment for Recurrent Hepatocellular Carcinoma

    by Katsunori Sakamoto, Tomoaki Yoh, Satoshi Nomura, Kentaro Kadono, Hidenobu Kojima, Asahi Sato, Shoichi Kageyama, Hirofumi Hirao, Takahiro Nishio, Shinya Okumura, et al.

    Purpose: This study aimed to investigate the prognostic impact of the interval between curative‐intent local treatments in patients undergoing repeated therapies for recurrent hepatocellular carcinoma after hepatectomy. Methods: The present retrospective cohort study included 890 patients who underwent hepatectomy for HCC at our hospital between 2001 and 2020. Overall survival (OS) was evaluated from the time of each curative‐intent local treatment, according to the number of treatments received and the intervals between consecutive curative‐intent treatments for intrahepatic recurrence, up to the fourth session. Results: During follow‐up, 625 patients (65.9%) developed intrahepatic recurrence. The median intervals gradually shortened to 24.9, 14.5, 12.4, and 12.8 months from hepatectomy to the first curative treatment, from the first to the second, from the second to the third, and from the third to the fourth treatments, respectively. For the first and second curative treatments, the pretreatment interval was not an independent predictor of OS. At the third curative treatment, an interval < 18.6 months between the second and third curative treatments independently predicted poorer OS (hazard ratio [HR] 2.280 and 95% confidence interval [CI] 1.046–4.967). For the fourth curative treatment, an interval < 14.1 months between the third and fourth treatments was an independent adverse prognostic factor (HR 4.961, 95% CI 1.607–15.319). The prognostic impact of treatment interval was more pronounced in patients who underwent ≥ 3 treatments, with a significant interaction compared with < 3 treatments. Conclusions: Among patients who remained eligible for repeated curative‐intent local treatment, a shortened interval between treatments in late‐phase recurrence was an independent predictor of poor prognosis.

  • Open Access

    Two-stage management of Amyand’s hernia with extensive inguinal abscess: laparoscopic appendiceal transection followed by laparoscopic hernia repair: a case report

    by Yasunori Shirakawa, Hirofumi Hirao, Hiroto Nishino, Tomoaki Yoh, Shinichi Fujita, Etsuro Hatano

    Introduction: Amyand’s hernia is a rare pathological condition characterized by the presence of the appendix in an inguinal hernia sac. In some cases, it is accompanied by perforated appendicitis, posing a challenging clinical scenario in which the surgeon must address both appendicitis with abdominal sepsis and hernia repair. Case presentation: A 78-year-old man presented to our hospital with a bulge in the right groin and was diagnosed with Amyand’s hernia with an extensive inguinal abscess on computed tomography. The patient underwent emergency laparoscopic appendiceal transection and groin percutaneous abscess drainage for perforated appendicitis within an inguinal hernia with a groin abscess. The patient was uneventfully discharged on postoperative day 10. Several months later, transabdominal preperitoneal repair with mesh for bilateral inguinal hernia and removal of the scarred residual appendix were performed as second-stage management. Discussion: Infection control should be prioritized in cases of perforated appendicitis with abscess formation. In cases with no or minimal inflammation, concurrent hernia repair with mesh and appendectomy may be feasible. However, considering the risk of infection, elective hernia repair with a mesh is the preferred approach after inflammation subsides. Conclusion: We highlighted the importance of individualized surgical management of Amyand’s hernia with severe inflammatory pathology.


  • Open Access

    Traumatic Ruptured Hepatic Cyst Managed by Laparoscopic Fenestration Assisted With Indocyanine Green (ICG) Fluorescence: A Case Report

    by Rikuto Uryu, Hirofumi Hirao, Kazuyuki Nagai, Satoshi Ogiso, Shinya Okumura, Tomoaki Yoh, Kei Yamane, Etsuro Hatano

    Nonparasitic hepatic cysts are common and generally asymptomatic. However, complications such as infection, hemorrhage, or rupture of the cyst necessitate therapeutic intervention. We report a rare case of traumatic rupture of a large hepatic cyst managed laparoscopically with the assistance of indocyanine green (ICG) fluorescence. A 57‐year‐old woman had been followed for 2 years for a large cystic lesion in segments 4 (S4) and 8 (S8) of the liver, suspected to be a mucinous cystic neoplasm (MCN). As the S4 cyst grew to 15 cm, surgical resection was planned. However, she presented to our emergency department after blunt abdominal trauma sustained from a fall at home. Computed tomography (CT) revealed rupture of the S4 cyst with massive ascites. Although initially managed conservatively with little abdominal symptoms, she developed worsening abdominal pain and progressive anemia 2 days postadmission, raising concern for cyst‐related hemorrhage and possible bile leakage. Emergent laparoscopic surgery revealed hemoperitoneum and bleeding from the ruptured cyst wall. ICG was administered intravenously immediately after anesthesia induction to visualize the communication between the cyst and the biliary tract by fluorescence imaging. Then, laparoscopic fenestration was performed under ICG guidance. The patient was discharged on postoperative day (POD) 6 without any complications. We successfully treated a rare case of traumatic hepatic cyst rupture by laparoscopic fenestration with ICG imaging. ICG fluorescence was a helpful adjunct for intraoperative assessment of the potential bile duct in the cyst, ensuring the safety of the operative procedure.

  • Open Access

    Pancreatic Neuroendocrine Tumor with Acinar Pattern Mimicking Pancreatic Ductal Adenocarcinoma: A Case Report

    by Yasunori Shirakawa, Kei Yamane, Kazuyuki Nagai, Shinya Otsuki, Masakazu Fujimoto, Kentaro Tsuji, Tomoaki Yoh, Shinya Okumura, Hirofumi Hirao, Satoshi Ogiso, et al.

    INTRODUCTION: Pancreatic neuroendocrine tumors (PanNETs) are rare, but their incidence has been increasing. PanNETs are usually diagnosed based on typical radiological and pathological findings. However, some exhibit unusual findings; therefore, we need to consider these and make a diagnosis through multidisciplinary evaluation. In this report, we present a case of PanNET that was challenging to diagnose preoperatively.CASE PRESENTATION: A man in his 70s with a prior diagnosis of intrahepatic cholangiocarcinoma (iCCA) was referred to our hospital (Kyoto University Hospital) for suspected recurrence of multiple intrahepatic metastases. MRI showed space-occupying lesions in the liver and a 2.7-cm hyperintense mass in the uncinate process of the pancreas. Adenocarcinoma was diagnosed by endoscopic US-guided tissue acquisition (EUS-TA) of the pancreatic lesion. Accordingly, the patient underwent neoadjuvant chemotherapy followed by pancreatoduodenectomy. However, postoperative histological and immunohistochemical evaluations of the surgically resected specimen revealed G2 PanNET with an unusual acinar structure that was not considered preoperatively.CONCLUSIONS: This case highlights the diagnostic challenge of unusual PanNETs that presented radiologically and pathologically with unusual features. A multidisciplinary evaluation and awareness of PanNETs with unusual features are essential for accurate diagnosis.

  • Robotic Hepatectomy Using the Hugo RAS System: Initial Experience and Technical Considerations

    by Katsunori Sakamoto, Hiroto Nishino, Tomoaki Yoh, Hidenobu Kojima, Asahi Sato, Hirofumi Hirao, Takahiro Nishio, Shinya Okumura, Daisuke Ueda, Kei Yamane, et al.

    Robotic hepatectomy using the Hugo robotic‐assisted surgery (RAS) system has recently been introduced; however, clinical experience remains limited. We report our initial experience in five patients, focusing on surgical techniques and short‐term outcomes. All procedures were completed robotically without conversion to open or laparoscopic surgery. The median operative time was 175 min (range, 162–209), and the median console time was 100 min (range, 79–139). The median inflow occlusion time was 31 min (range, 14–62). Intraoperative blood loss was minimal, with a median of 0 mL (range, 0–10). No intraoperative or postoperative complications were observed. The median postoperative hospital stay was 7 days (range, 4–11). The series included lesions in both left‐ and right‐sided liver segments, including technically demanding areas such as segment 7. These findings suggest that Hugo RAS minor hepatectomy appears feasible and safe in selected cases, with favorable short‐term outcomes.

  • Open Access

    Recipient toll-like receptor 4 determines the outcome of ischemia-reperfusion injury in steatotic liver transplantation in mice

    by Kosuke Tanaka, Yoichiro Uchida, Kentaro Kadono, Shoichi Kageyama, Hiroshi Kawamoto, Masaaki Ito, Yuki Kidoguchi, Kenichi Saga, Hidenobu Kojima, Hirofumi Hirao, et al.


  • Open Access

    Cold stress–induced ferroptosis in liver sinusoidal endothelial cells determines liver transplant injury and outcomes

    by Hidenobu Kojima, Hirofumi Hirao, Kentaro Kadono, Takahiro Ito, Siyuan Yao, Taylor Torgerson, Kenneth J. Dery, Hiroaki Kitajima, Takahiro Ogawa, Fady M. Kaldas, et al.

    Although cold preservation remains the gold standard in organ transplantation, cold stress–induced cellular injury is a significant problem in clinical orthotopic liver transplantation (OLT). Because a recent study showed that cold stress activates ferroptosis, a form of regulated cell death, we investigated whether and how ferroptosis determines OLT outcomes in mice and humans. Treatment with ferroptosis inhibitor (ferrostatin-1) during cold preservation reduced lipid peroxidation (malondialdehyde; MDA), primarily in liver sinusoidal endothelial cells (LSECs), and alleviated ischemia/reperfusion injury in mouse OLT. Similarly, ferrostatin-1 reduced cell death in cold-stressed LSEC cultures. LSECs deficient in nuclear factor erythroid 2-related factor 2 (NRF2), a critical regulator of ferroptosis, were susceptible to cold stress–induced cell death, concomitant with enhanced endoplasmic reticulum (ER) stress and expression of mitochondrial Ca 2+ uptake regulator (MICU1). Indeed, supplementing MICU1 inhibitor reduced ER stress, MDA expression, and cell death in NRF2-deficient but not WT LSECs, suggesting NRF2 is a critical regulator of MICU1-mediated ferroptosis. Consistent with murine data, enhanced liver NRF2 expression reduced MDA levels, hepatocellular damage, and incidence of early allograft dysfunction in human OLT recipients. This translational study provides a clinically applicable strategy in which inhibition of ferroptosis during liver cold preservation mitigates OLT injury by protecting LSECs from peritransplant stress via an NRF2-regulatory mechanism.


  • Alternative splicing of CEACAM1 by hypoxia-inducible factor–1α enhances tolerance to hepatic ischemia in mice and humans

    by Kenneth J. Dery, Hidenobu Kojima, Shoichi Kageyama, Kentaro Kadono, Hirofumi Hirao, Brian Cheng, Yuan Zhai, Douglas G. Farmer, Fady M. Kaldas, Xiaoyi Yuan, et al.

    Although alternative splicing (AS) drives transcriptional responses and cellular adaptation to environmental stresses, its contributions in organ transplantation have not been appreciated. We have shown that carcinoembryonic antigen–related cell adhesion molecule (Ceacam1; CD66a ), a transmembrane biliary glycoprotein expressed in epithelial, endothelial, and immune cells, determines donor liver transplant quality. Here, we studied how AS of Ceacam1 affects ischemia-reperfusion injury (IRI) in mouse and human livers. We found that the short cytoplasmic isoform Ceacam1-S increased during early acute and late resolution phases of warm IRI injury in mice. Transfection of Ceacam1-deficient mouse hepatocytes with adenoviral Ceacam1-S mitigated hypoxia-induced loss of cellular adhesion by repressing the Ask1/p-p38 cell death pathway. Nucleic acid–blocking morpholinos, designed to selectively induce Ceacam1-S, protected hepatocyte cultures against temperature-induced stress in vitro. Luciferase and chromatin immunoprecipitation assays identified direct binding of hypoxia-inducible factor–1α (Hif-1α) to the mouse polypyrimidine tract binding protein 1 ( Ptbp1 ) promoter region. Dimethyloxalylglycine protected mouse livers from warm IR stress and hepatocellular damage by inhibiting prolyl hydroxylase domain–containing protein 1 and promoting AS of Ceacam1-S . Last, analysis of 46 human donor liver grafts revealed that CEACAM1-S positively correlated with pretransplant HIF1A expression. This also correlated with better transplant outcomes, including reduced TIMP1 , total bilirubin, proinflammatory MCP1 , CXCL10 cytokines, immune activation markers IL17A , and incidence of delayed complications from biliary anastomosis. This translational study identified mouse Hif-1α–controlled AS of Ceacam1 , through transcriptional regulation of Ptbp1 promoter region, as a functional underpinning of hepatoprotection against IR stress and tissue damage in liver transplantation.